Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin bolus dose-finding study for prevention of uterine atony during elective cesarean delivery in older women with prior cesarean delivery
ChiCTR2000038890Phase 4Recruiting
- Sponsor
- Jiaxing Maternity and Child Health Care Hospital
- Start
- Oct 2020
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of oxytocin in uterine atony (6 arms), sponsored by Jiaxing Maternity and Child Health Care Hospital. Primary endpoints: Oxytocin effective dose in 50% of parturients (ED50) for adequate uterine tone, Oxytocin effective dose in 90% of parturients (ED90) for adequate uterine tone and 5 more. Started Oct 2020; status: recruiting.
02
Drugs
oxytocin
03
Conditions
uterine atony
Beyond the preview
Go deeper on ChiCTR2000038890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038890.